Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) announced the latest research results of its self-developed products Schwarzhe® (generic name: sulvortinib tablets), and DZD6008 in the field of non-small cell lung cancer (NSCLC) at the American Society of Clinical Oncology (ASCO) annual meeting to be held in Chicago from May 29 to June 2, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.